Literature DB >> 17565610

Lung macrophages from bacille Calmette-Guérin-vaccinated guinea pigs suppress T cell proliferation but restrict intracellular growth of M. tuberculosis after recombinant guinea pig interferon-gamma activation.

A Jeevan1, K Majorov, K Sawant, H Cho, D N McMurray.   

Abstract

The guinea pig model of low-dose pulmonary tuberculosis has been used to study the pathogenesis of infection as well as the mechanisms of bacille Calmette-Guérin (BCG) vaccine-induced resistance. We investigated the function of lung cells from naive and BCG-vaccinated guinea pigs after enzymatic digestion of lung tissue with collagenase and DNase I. The total lung digest cells proliferated poorly to purified protein derivative (PPD) but comparatively better to ConA as assessed by [(3)H]-thymidine uptake. However, the non-adherent population obtained after plastic adherence of lung digests showed an enhanced response to concanavalin A (ConA) and PPD. Therefore, proliferation to ConA and PPD of nylon wool-purified T cells co-cultured with peritoneal (PMøs), alveolar (AMøs) or lung macrophages (LMøs) was assessed. Co-cultures of lung T cells and PMøs showed maximum proliferation to PPD, whereas proliferation was suppressed significantly by the addition of AMøs or LMøs. The response of T cells to ConA was unaffected in co-cultures. Incubation of co-cultures with recombinant guinea pig interferon-gamma (rgpIFN-gamma) did not reverse the suppression. In contrast, rgpIFN-gamma-treated plastic adherent LMøs that were non-specific esterase-positive were capable of reducing the intracellular growth of Mycobacterium tuberculosis. Similarly, total, non-adherent and adherent lung digest cells from BCG-vaccinated guinea pigs showed IFN-gamma and tumour necrosis factor (TNF)-alpha mRNA expression in response to ConA, lipopolysaccharide or PPD by reverse transcription-polymerase chain reaction followed by release of TNF protein but not IFN. These studies indicate that rgp-IFN-gamma-treated lung tissue macrophages from BCG-vaccinated guinea pigs are defective for inducing antigen-specific proliferation in T cells, but control the intracellular accumulation of virulent M. tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17565610      PMCID: PMC1941958          DOI: 10.1111/j.1365-2249.2007.03425.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  53 in total

1.  Suppression of lymphoproliferation by alveolar macrophages in the guinea pig.

Authors:  X Zhang; D N McMurray
Journal:  Tuber Lung Dis       Date:  1998

2.  Selective inhibition of T cell proliferation but not expression of effector function by human alveolar macrophages.

Authors:  J W Upham; D H Strickland; B W Robinson; P G Holt
Journal:  Thorax       Date:  1997-09       Impact factor: 9.139

Review 3.  BCG vaccination against tuberculosis: past disappointments and future hopes.

Authors:  P W Roche; J A Triccas; N Winter
Journal:  Trends Microbiol       Date:  1995-10       Impact factor: 17.079

4.  Induction of gamma interferon production in human alveolar macrophages by Mycobacterium tuberculosis.

Authors:  M J Fenton; M W Vermeulen; S Kim; M Burdick; R M Strieter; H Kornfeld
Journal:  Infect Immun       Date:  1997-12       Impact factor: 3.441

5.  Dissociation between cytokine mRNA expression and protein production in shigellosis.

Authors:  R Raqib; A Ljungdahl; A A Lindberg; B Wretlind; U Andersson; J Andersson
Journal:  Eur J Immunol       Date:  1996-05       Impact factor: 5.532

6.  Guinea pig Kurloff (NK-like) cells mediate TNF-dependent cytotoxic activity: analogy with NC effector cells.

Authors:  N Pouliot; K Maghni; P Sirois; M Rola-Pleszczynski
Journal:  Inflammation       Date:  1996-06       Impact factor: 4.092

7.  Alveolar macrophages from humans and rodents selectively inhibit T-cell proliferation but permit T-cell activation and cytokine secretion.

Authors:  J W Upham; D H Strickland; N Bilyk; B W Robinson; P G Holt
Journal:  Immunology       Date:  1995-01       Impact factor: 7.397

8.  Cytokine modulation of the immunosuppressive phenotype of pulmonary alveolar macrophage populations.

Authors:  N Bilyk; P G Holt
Journal:  Immunology       Date:  1995-10       Impact factor: 7.397

Review 9.  BCG vaccination in India and tuberculosis in children: newer facets.

Authors:  P M Udani
Journal:  Indian J Pediatr       Date:  1994 Sep-Oct       Impact factor: 1.967

10.  An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection.

Authors:  J L Flynn; J Chan; K J Triebold; D K Dalton; T A Stewart; B R Bloom
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

View more
  10 in total

1.  The in vivo immunomodulatory effect of recombinant tumour necrosis factor-alpha in guinea pigs vaccinated with Mycobacterium bovis bacille Calmette-Guérin.

Authors:  J C Kramp; D N McMurray; C Formichella; A Jeevan
Journal:  Clin Exp Immunol       Date:  2011-05-05       Impact factor: 4.330

2.  Rate of recipient-derived alveolar macrophage development and major histocompatibility complex cross-decoration after lung transplantation in humans.

Authors:  Mark E Snyder; Anna Bondonese; Andrew Craig; Iulia Popescu; Matthew R Morrell; Michael M Myerburg; Carlo J Iasella; Elizabeth Lendermon; Joseph Pilweski; Bruce Johnson; Silpa Kilaru; Yingze Zhang; Humberto E Trejo Bittar; Xingan Wang; Pablo G Sanchez; Fadi Lakkis; John McDyer
Journal:  Am J Transplant       Date:  2021-09-07       Impact factor: 9.369

3.  TGF-beta and CD23 are involved in nitric oxide production by pulmonary macrophages activated by beta-glucan from Paracoccidioides brasiliensis.

Authors:  Luiz de Pádua Queiroz; Marden Estevão Mattos; Marcelo Fernandes da Silva; Célio Lopes Silva
Journal:  Med Microbiol Immunol       Date:  2009-12-01       Impact factor: 3.402

4.  Neutralization of TNFalpha alters inflammation in guinea pig tuberculous pleuritis.

Authors:  Lan H Ly; Amminikutty Jeevan; David N McMurray
Journal:  Microbes Infect       Date:  2009-04-21       Impact factor: 2.700

5.  Molecular cloning, expression, and in silico structural analysis of guinea pig IL-17.

Authors:  Vijaya R Dirisala; Amminikutty Jeevan; Suresh K Ramasamy; David N McMurray
Journal:  Mol Biotechnol       Date:  2013-11       Impact factor: 2.695

6.  Expression of interferon-gamma and tumour necrosis factor-alpha messenger RNA does not correlate with protection in guinea pigs challenged with virulent Mycobacterium tuberculosis by the respiratory route.

Authors:  Amminikutty Jeevan; Diana Lucia Bonilla; David Neil McMurray
Journal:  Immunology       Date:  2008-11-07       Impact factor: 7.397

Review 7.  The Progress of Therapeutic Vaccination with Regard to Tuberculosis.

Authors:  Pere-Joan Cardona
Journal:  Front Microbiol       Date:  2016-09-28       Impact factor: 5.640

Review 8.  Immune Responses to Bacillus Calmette-Guérin Vaccination: Why Do They Fail to Protect against Mycobacterium tuberculosis?

Authors:  Juan I Moliva; Joanne Turner; Jordi B Torrelles
Journal:  Front Immunol       Date:  2017-04-05       Impact factor: 7.561

Review 9.  Progressive Host-Directed Strategies to Potentiate BCG Vaccination Against Tuberculosis.

Authors:  Kriti Negi; Ashima Bhaskar; Ved Prakash Dwivedi
Journal:  Front Immunol       Date:  2022-07-28       Impact factor: 8.786

10.  Protective immune mechanisms of Yifei Tongluo, a Chinese herb formulation, in the treatment of mycobacterial infection.

Authors:  Xin Fan; Ning Li; Xiaoshuang Wang; Jingyu Zhang; Meiyi Xu; Xueting Liu; Beinan Wang
Journal:  PLoS One       Date:  2018-09-11       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.